Psychedelic News2026-04-29T11:47:28+02:00

News and Press Releases

News and Press Releases

Psyence In The News

In The News Psyence Logo Blue - Psilocybin
Psyence wins ISO certification from
British Standards Institute for
psilocybin production facility
Psyence Group’s functional mushroom brand
to be sold in South Africa’s
largest coffee retail chain
Psyence Group begins trading on the
OTCQB platform in New York
to satisfy investor demand
Psyence Group launches its functional
mushroom products under the
GOODMIND banner in South Africa
In this interview with Proactive Investors, Dr. Neil Maresky
talks about his appointment as
CEO of Psyence Group.
Psyence Group ‘delighted’ to reach
psilocybin product development
agreement with Jamaican government

Market For Psychedelic Drugs Expected to Reach $6.9 Billion By 2027

Psychedelic Finance chats to Psyence CEO Jody Aufrichtig

Psyence looking to be a major player
in psychedelics using their federally
licensed facilities
Jody Aufrichtig in conversation
with the CSE’s
Barrington Miller

Contact Info

General inquiries — info@psyence.com

Media inquiries — media@psyence.com

Investor inquiries — ir@psyence.com

Tel: +1-416-477-1708

Address: 121 Richmond Street West, Penthouse Suite, 1300, Toronto ON M5H2K1, Canada

Sign Up To Our Newsletter

Sign Up To Receive Our Communications

By submitting this form, you are consenting to receive marketing emails from: Psyence Group Inc, 121 Richmond Street West, Penthouse Suite, 1300, Toronto ON M5H2K1 Canada You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email.
Go to Top